Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,152
Closed -$392K 186
2024
Q1
$392K Sell
5,152
-958
-16% -$71.3K 0.07% 85
2023
Q4
$443K Sell
6,110
-2,472
-29% -$172K 0.07% 112
2023
Q3
$591K Buy
8,582
+2,445
+40% +$185K 0.19% 81
2023
Q2
$490K Buy
+6,137
New +$502K 0.12% 69
2023
Q1
Sell
-7,955
Closed -$601K 224
2022
Q4
$601K Sell
7,955
-600
-7% -$42.7K 0.26% 44
2022
Q3
$566K Sell
8,555
-817
-9% -$56.6K 0.29% 34
2022
Q2
$649K Buy
+9,372
New +$696K 0.17% 74
2015
Q4
Sell
-112
Closed -$4K 225
2015
Q3
$4K Buy
+112
New +$4.44K ﹤0.01% 161

Other funds holding HOLX

Advisors Preferred's HOLX Position: Q2 2024 in Review

Advisors Preferred sold out of Hologic (HOLX) in Q2 2024, closing a stake of 5,152 shares — an estimated $392K sold.

Advisors Preferred first reported a position in HOLX in Q3 2015 and held it in 8 quarters. The position peaked at $649K in Q2 2022. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Advisors Preferred reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Advisors Preferred sold 5,152 Hologic shares in Q2 2024, an estimated $392K.
  • Advisors Preferred first reported a position in Hologic in Q3 2015 and held it in 8 quarters.
  • Advisors Preferred's Hologic position peaked at $649K in Q2 2022.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Advisors Preferred's 13F filing for Q2 2024, filed 30 Jul 2024.